Few alternatives to estrogen treatment in vegetative symptoms after the menopause;Få alternativ till östrogenbehandling vid vegetativa besvär efter menopaus

Lakartidningen

Volumn 101, Issue 18, 2004, Pages 1612-1616

  Hammar, Mats ^b   Nedstrand, Elizabeth ^c   Wyon, Yvonne ^a  

^a Halsouniversitetet   (Sweden)

^b Avdelningen Obstetrik Och Gynekologi   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CALCITONIN GENE RELATED PEPTIDE; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; ESTROGEN; ESTROGEN RECEPTOR BETA; FLUOXETINE; FOLLITROPIN; GENISTEIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NEUROPEPTIDE; PAROXETINE; PHYTOESTROGEN; RED CLOVER EXTRACT; TAMOXIFEN; VENLAFAXINE; PLANT MEDICINAL PRODUCT;

AUTONOMIC DYSFUNCTION; CIMICIFUGA RACEMOSA; ESTROGEN THERAPY; FEMALE; GINSENG; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; RED CLOVER; REVIEW; ACUPUNCTURE; ADRENERGIC SYSTEM; AGED; BEHAVIOR THERAPY; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG EFFECT; EXERCISE; HOT FLUSH; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; RELAXATION TRAINING;

ACUPUNCTURE THERAPY; AGED; BEHAVIOR THERAPY; DIETARY SUPPLEMENTS; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PLANT PREPARATIONS; RELAXATION TECHNIQUES; VASOMOTOR SYSTEM;

EID: 2942555447     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-33.
2. Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, et al for the HERS Study Group. Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002;105:2962-7.
3. McKinley S, Brambilla D, Posner J. The normal menopause transition. Maturitas 1992;14:103-15.
4. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501-9.
5. Wyon Y, Lindgren R, Lundeberg T, Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women. Menopause 1995;2:3-12.
6. Wyon Y, Spetz AC, Theodorsson E, Hammar M. Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 2000; 7:25-30.
7. Nedstrand E, Wijma K, Lindgren M, Hammar M. The relationship between stress-coping and vasomotor symptoms in postmenopausal women. Maturitas 1998;31:29-34.
8. Walker LG, Walker MB, Ogston K, Heys SD, Ah-see AK, Miller ID, et al. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Brit J Cancer 1999;80:262-8.
9. Stadberg E, Mattsson LÅ, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand 1997;76:442-8.
10. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13.
11. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, et al. Evaluation of soy phytoestrogens for the treatment of hot flushes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol 2000;18:1068-74.
12. Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003;79:1112-7.
13. Nikander E, Kilkkinen A, Metsa-Heikkila M, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 2003;101:1213-20.
14. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19: 2739-45.
15. van der Weijer P, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187.
16. Lindh-Åstrand L, Nedstrand E, Wyon Y, Hammar M. The effects of physical activity and estrogens on vasomotor symptoms and quality of life in postmenopausal women. Maturitas. In press 2004.
17. Freedman R, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-9.
18. Bertelli G, Venturini M, Del Mastro L, Bergaglio M, Sismondi P, Biglia N, et al. Intramuscular depot medroxyprogesterone versus megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Ann Oncol 2002;13:883-8.
19. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flushes. J Clin Oncol 2002;20:1578-83.
20. Loprinzi CI, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DI, et al. Venlafaxin in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356:2025-6.